Document is current
Any future updates will be listed below
-
Authors
Zhou, Wen-Da
Dong, Li
Li, Wen-Xue
Fang, Li-Jian
Ma, Tong
Ju, Lie
Wang, Zhao-Hui
Luo, Yuan
Zhang, Wanli Miles
Chang, Xian-Gang
Ge, Zong-Yuan
Jonas, Jost. B.
Wei, Wen-Bin
- License Information
-
More Information
Article History
Received: 6 February 2025
Accepted: 16 June 2025
First Online: 16 July 2025
Compliance and ethics
: Jost B. Jonas: European patent EP 3 271 392, JP 2021119187, and U.S. Patent No. US 12,024,557 B2: Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia; European patent application 23196899.1 ‘EGFR Antagonists for the treatment of diseases involving unwanted migration, proliferation, and metaplasia of retinal pigment epithelium (RPE) cells’. All other authors declare no financial interest.
